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Nerve tissue engineeringPeripheral nerve injury is a debilitating condition. The gold standard for treatment is surgery, requiring an
autologous nerve graft. Grafts are harvested from another part of the body (a secondary site) to treat the af-
fected primary area. However, autologous nerve graft harvesting is not without risks, with associated prob-
lems including injury to the secondary site. Research into biomaterials has engendered the use of
bioartiﬁcial nerve conduits as an alternative to autologous nerve grafts. These include synthetic and artiﬁcial
materials, which can be manufactured into nerve conduits using techniques inspired by nanotechnology. Re-
cent evidence indicates that peptide amphiphiles (PAs) are promising candidates for use as materials for bio-
engineering nerve conduits. PAs are biocompatible and biodegradable protein-based nanomaterials, capable
of self-assembly in aqueous solutions. Their self-assembly system, coupled with their intrinsic capacity for car-
rying bioactive epitopes for tissue regeneration, form particularly novel attributes for biochemically-engineered
materials. Furthermore, PAs can function as biomimetic materials and advanced drug delivery platforms for
sustained and controlled release of a plethora of therapeutic agents. Here we review the realm of nerve conduit
tissue engineering and the potential for PAs as viable materials in this exciting and rapidly advancing ﬁeld.
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Peripheral nerve injury is a critical and disabling condition. Every
year, around 100,000 patients in the USA and Europe undergo nerve
surgery for the purpose of rectifying it [1]. With a small transectionnerative Medicine, University
l.: +44 207 830 2901.
eifalian).
rights reserved.gap of less than 20 mm between nerves, it is possible to surgically re-
pair it by reapproximating the ends of the injured nerve via direct ap-
position using sutures. However, when lesion gaps are greater than
20 mm, current clinical gold standard dictates the performance of au-
tologous nerve grafting [2]. Nevertheless, there are signiﬁcant com-
plications associated with this technique. An autologous nerve graft
is harvested from another part of the body (the donor site) for use
in the lesion (recipient site) in question. This necessitates the gener-
ation of a secondary injury at the donor site. Unresolved issues
Fig. 1. An ideal nerve conduit. A nerve conduit should ideally possess attributes that would allow it to support the growth and regeneration of neural cells. Nutrients and growth
factors are vital for neural cell regeneration. Copyright © 2006 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd. Reproduced with permission from [4].
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neuroma; and the possible loss of sensation and function at the donor
site [3].
To address these disconcerting attributes of autologous nerve
grafting, biochemical engineering of nerve conduits has emerged as
an alternative technique. A nerve conduit should ideally possess fea-
tures that permit the regeneration and reanimation of both endoge-
nous and exogenous neural cells [4] (Fig. 1).
The most important characteristic that a bioartiﬁcial nerve conduit
must possess is biocompatibility. This means that the material must
not be toxic, and its presence in the body should not elicit an immu-
nological response. If the material used is biodegradable, its degrada-
tion kinetics should match the rate of nerve tissue regeneration to
ensure an optimal healing process. Design parameters should encom-
pass aspects like adequate porosity to facilitate the delivery of nutrients
to the regenerating neural cells, and appropriate nanotopography to
promote cell adhesion and proliferation [5]. Furthermore, these nerve
conduits should also be engineered in such a way that the constituent
ﬁbers possess adequate tensile strengthwithout compromising ﬂexibil-
ity [6].
Recent evidence suggests that peptide amphiphiles (PA) are able
to fulﬁll these design criteria, and are emerging as a viable material
for bioengineering nerve conduits [7]. PAs have a dual functionality
of simultaneously being hydrophobic and hydrophilic, with the addi-
tional ability of delivering bioactive molecules to the site of injury [8].
Their supramolecular arrangement allows for the spontaneous self-
assembly of nanoﬁbers [9] (Fig. 2).
This balance of polarity between attractive and repulsive forces
within the nano-molecular construct further alludes to their novel
properties [10]. In this review, we seek to explore the realm of
bioartiﬁcal nerve conduit engineering, and expound on the concept
of using PAs for the biochemical engineering of nerve conduits.2. Biochemical engineering nerve conduits
2.1. Overview
Nerve tissue engineering is a rapidly evolving and expanding ﬁeld
in the realm of biomedicine. A multitude of in vitro and in vivo studies
have been conducted to assess the viability of different materials, andfeasibility of different fabrication methods for building the ideal nerve
conduit (Table 1).
Materials used for manufacturing nerve conduits can be catego-
rized into 2 classes: synthetic [11] and natural [12]. Synthetic mate-
rials include aliphatic polyesters, polyurethanes, polyphosphoesters,
piezoelectric polymers, and hydrogel-based materials. In contrast,
natural materials are derived from animals, with some examples in-
cluding decellularized scaffolds, polysaccharides (e.g. chitosan), and
collagen.
Aliphatic polyesters are a class of polymers, and some examples are:
polylactic acid (PLA), polyglycolic acid (PGA)[13,14], polycaprolactone
(PCL)[15–17], poly(3-hydroxybutyrate) (PHB), and poly(lactic-co-
glycolic acid) (PLGA)[18–20]. These polymers are biocompatible, and
can be synthesized into ﬁbers via a method called electrospinning
[21]. Electrospinning is a fabrication technique whereby an electric
charge is used to produce exceedingly ﬁne (in the nanoscale) ﬁbers
[22]. There is evidence to suggest that neural cells can adhere to and
proliferate on these nanoﬁber assemblies [23–26].
Natural materials like laminin [27], collagen and chitosan [28,29]
have also been investigated as scaffolds for nerve conduits. In addi-
tion, semi-natural materials like poly(epsilon-caprolactone)/gelatin
and nanoﬁber-collagen composites have also been explored as possi-
ble materials for constructing nerve conduits [30,31]. These hybrid
materials harbor the intrinsic qualities from both natural and synthetic
materials [32–34].
2.2. Design considerations
In addition to selecting the appropriate material, it is imperative to
have optimal design parameters that would allow nerve conduits to
espouse characteristics of actual nerves. For instance, it is imperative
for neural cells in the nerve conduit to obtain nutrients and growth
factors [35] (Fig. 3).
Porosity is one factor that determines the ﬂow of essential growth
molecules, and plays an important role for neural and axonal regenera-
tion [36,37]. Self-assembling peptide nanoﬁbers have been propounded
as possible materials for constructing nerve conduits [38,39], with sev-
eral studies indicating their ability to support neural progenitor cell
growth and differentiation [40,41].
Different nerve conduit materials have been experimented for
use in humans (Table 2), and some examples include expanded
Fig. 2. Peptide amphiphiles. A Chemical structure of a peptide amphiphile, encompassing: (1) A hydrophobic alkyl tail, (2) Four cysteine residues for self-assembly, (3) Linker region
of three glycine residues for hydrophilic head group, (4) A phosphorylated serine residue for mineralization, (5) A bioactive epitope. B Molecular model of a PA. C Self-assembly of
PA molecules into a cylindrical micelle. Copyright © 2001 American Association for the Advancement of Science. Reproduced with permission from [9].
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(PLCL)[46,47], polyglycolic acid (PGA)[48–56], silicone [57–64] and
collagen [65–69]. The US Food & Drug Administration (FDA) has ap-
proved several nerve conduits for clinical use (Table 3), and they are
generally hollow tubes made from materials like collagen, PGA, PLCL
or alcohol-based hydrogels [1,70,71] (Fig. 4).
3. Peptide amphiphiles
3.1. Structure
Peptide amphiphiles (PAs) are self-assembling peptides with the
ability to form nanoﬁbers. PAs typically have 4 regions: a hydrophobicalkyl chain, a beta-sheet forming segment, a peptide charged segment,
and a customizable bioactive epitope [72] (Fig. 5). Its capacity for
self-assembly can largely be attributed to the balance of attractive and
repulsive forces within its nano-architectural arrangement [73]. Evi-
dence indicates that PAs can be used to construct nerve conduits
(Table 4). PAs are biodegradable [74] and does not elicit an appreciable
immunological response, underscoring its potential to be a promising
material for nerve conduits. Further, the products of degradation are
sugars and amino acids, and therefore are not toxic to biological sys-
tems. In contrast to PAs, many polymers tend to degrade into products
that might not always be biocompatible and can elicit an immune reac-
tion. PAs can also be considered “polymers” of amino acidswith charged
groups. Hence, the conﬁguration of its nano-architecture can be
Table 1
Bioengineering nerve conduits. Keys: ES, electrospinning; SD, Sprague–Dawley.
Scaffold material In vitro/vivo Fabrication
technique
Overview Ref
• Polyamide nanoﬁbers
• Functionalized with tenascin-C derived peptides
In vitro ES • Nanoﬁbrillar
• Synthetic
• Neurites had a greater total length than on PLL control
[11]
Poly (2- Hydroxyethyl methacrylate-co-methyl methacry-
late) (PHEMA-MMA)
hollow porous tubes
Lewis rats Molding via
centrifugal forces
• Axonal regeneration within 8 weeks
• Regeneration was comparable to autografts in 60% of rats
[36]
• Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)(
PHBHHx) conduit
• Uniform and non-uniform wall porosity
SD rats Dipping-leeching
method
Non-uniform wall porosity had results similar to autograft control [37]
• Copolymer of ε-caprolactone and ethyl ethylene phos-
phate (PCLEEP)
• Microﬁborous scaffold functionalized nerve growth fac-
tor (NGF)
In vitro ES • Sustained release of NGF over 3 month period
• Fibers partially aligned
Stimulates neuronal differentiation
[16]
Poly(ε-caprolactone) (PCL) microﬁbers In vitro ES • Cells align with ﬁber axis
Schwann cells shown neuronal differentiation on both aligned and un-
aligned ﬁbers
[15]
Polydioxanone (PDO) microﬁbers In vitro ES • Aligned ﬁbers directed neuronal growth
• Directionality not observed on unaligned ﬁbers
[21]
Poly-L-lactate (PLL) microﬁbers In vitro ES Aligned ﬁbers increase neurite length and direct growth [13]
Self assembling peptide nanoﬁber Syrian
hamsters
Self-assembly Functional return of vision after severing of the optic tract [38]
• Self-assembling peptide nanoﬁber
• RADA16 (Ac-RADARADARADARADA-COHN2)
Functionalized with motifs from collagen, laminin, ﬁbrin,
ﬁbronectin, osteopontin, and osteogenic peptides
In vitro Self-assembly • Scaffolds with bone marrow homing motifs signiﬁcantly enhanced cell
survival
• On these scaffolds, the % of cells expressing neuronal markers was sim-
ilar to that on Matrigel
[39]
Poly(3-caprolactone) and porcine gelatin blend In vitro ES • Differentiation and proliferation enhanced with respect to PCL
nanoﬁbrous scaffolds
• Randomly oriented ﬁbers did show good results, but ﬁber alignment
enhanced these effects
[30]
• Self-assembling peptide nanoﬁber scaffold
• Pre-cultured with neural progenitor cells and Schwann
cells prior to implant
SD rats Self-assembly • Progenitor cell survival, differentiation and migration observed both in
vivo and in vitro
• Vascularisation of scaffolds observed
[40]
• Micropatterned laminin
• Patterned using aligned microﬁbers of poly(D,
L-lactide-co-glycolic
• acid) (PLGA)
Functionalized with nerve growth factor
In vitro ES • Under the inﬂuence of ﬂuid sheer stress, most cultured progenitors
differentiated into neurons
• Neurons aligned to ﬁbers
[18]
• Poly(acrylonitrile-comethylacrylate (PAN-MA)
sub-micron aligned ﬁber ﬁlms
• Films stacked within a hollow polysulfone nerve conduit
In vitro &
rats
ES • Aligned constructs promoted axonal regeneration across a 17 mm gap
• Recovery of ﬁne motor control was increased with respect to unaligned
ﬁbers
[23]
• Nanoﬁbrous copolymer of methyl methacrylate and
acrylic acid (PMMAAA)
Functionalized by immobilization of collagen onto the
nanoﬁber surface
In vitro ES Cell viability assay and metabolic activity assay indicate that this is a
suitable material for cell growth.
[31]
• Nanoﬁbrous blend of (C28O4N4H47)n and
(C27O4.4N4H50)n
Functionalized with tenascin-C derived peptides
SD rats ES • Functionalization increased axonal regrowth
• Randomly orientated ﬁbers impeded regrowth
[22]
Murine laminin-1 nanoﬁbrous mesh In vitro ES • Progenitors exhibited neurite growth without addition of growth fac-
tors
• Rate and quality of attachment was greater than on laminin ﬁlms
[27]
• Poly(L-lactide) (PLLA) nanoﬁbers
• Poly(lactide-co-glycolide) (PLGA) nanoﬁbers
• Surface treated with KOH to reduce surface tension
In vitro ES • Both substrates exhibited cellular growth and attachment
• If the inter-ﬁber distance is greater than 15 μm, the neurons follow the
ﬁbers
• Neurons travel perpendicular to the ﬁbers at lower inter-ﬁber
distances.
• Neurites did not extend into regions with inter-ﬁber distances b1 μm
[19]
• Collagen tubes
• Functionalized with luminal collagen ﬁlaments
Beagle dogs Winding of ﬁber • Does not elicit immune response
• Minimal scar tissue formed
• Functional recovery within 52 weeks
[12]
• Poly(lactic-co-glycolic acid) (PLGA)and
polycaprolactone(PCL) blend
• Nanoﬁbrous tubes
• Tubes ﬁlled with saline
SD rats ES • Regeneration of nerves through lesion
• Functional nerve reconnection
• No signiﬁcant immune response
[20]
• Poly(L-lactide) (PLLA) nanoﬁbers
Covalently functionalized with bFGF and laminin
In vitro ES • Synergistic effect of ﬁber alignment and functionalization
• Cell migration higher than in untreated group
• Neurite extension was increased with respect to untreated animals
[14]
Nanoﬁbrous PCL/chitosan blend In vitro ES • Increased cell proliferation and attachment with respect to PCL alone
• Schwann cells maintained phenotype after growth on scaffold
[32]
• 5 different microﬁbrous scaffold materials
• Poly(3-hydroxybutyrate) (PHB)
• Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)
• Poly(L-lactic acid) (PLLA)
• Chitosan (CS)
Polycaprolactone (PCL)
In vitro ES/casting • Cell attachment greatest on the PCL ﬁlm
• Cells were able to penetrate into all nanoﬁbrous scaffolds except PCL
[33]
(continued on next page)
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Table 1 (continued)
Scaffold material In vitro/vivo Fabrication
technique
Overview Ref
Poly-ε-caprolactone and collagen/poly-ε-caprolactone
(c/PCL) blend nanoﬁbers
In vitro ES • Both ﬁber types supported neurite outgrowth from dorsal root ganglia
explants
• Migration and neurite orientation of Schwann cells were improved on
c/PCL blend compared to PCL alone
[34]
• Cross-linked poly(ε-caprolactone fumarate) of 3 molecular
weights; 530, 1250, and 2000 g mol−1
Hollow tubular conduit
In vivo and
in vitro, rats
Glass mold • 2000 g mol−1 provided best cell attachment and proliferation
• Myelinated nervous tissue was found within the conduit after both 6
and 17 weeks of implantation
[17]
• Poly(3-hydroxybutyrate)
• Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
• Microﬁbrous mats compared to ﬁlms
In vitro ES • RT4-D6P2T cell attachment and proliferation were higher on ﬁlms than
ﬁber mats
• L929 attach and proliferate better on ﬁber mats
[24]
• Self-assembling RADA16-I peptides
• PFSSTKT functional epitope was interspersed within the
RADA16-1 ﬁbers
• Glycerine spacers were used to separate the RADA16-1
and PFSSTKT within the ﬁber
The no. of spacers was varied from 0 to 4
In vitro Self-assembly Spacers are important in ensuring that the PFSSTKT epitope is exposed to
the environment, as opposed to being hidden within molecule
[41]
• Non-woven chitosan nano/microﬁber mesh tubes
Introduced glycine spacers into CYIGSR sequence
SD rats ES and molding Enhanced nerve regeneration [29]
Chitosan non-woven micro/nanoﬁber mesh tubes SD rats ES and molding Functions as a scaffold for neural cell migration, attachment and nerve
regeneration
[28]
• Chitosan-poly-lactic acid mix
• Hollow nerve conduit
SD rats Rotating
mandrel
• Material is not cytotoxic in vitro
• Chitosan-PLA conduit more effective than silicone conduit at restoring
sciatic nerve function
[25]
Aligned poly(ε-caprolactone) (PCL) nanoﬁbers In vitro ES • Promotes differentiation of cultured embryonic stem cells into neural
lineages.
• Aligned ﬁbers direct neurite growth
[26]
346 A. Tan et al. / Journal of Controlled Release 163 (2012) 342–352modulated by changes in pH [75]. This therefore highlights the impor-
tance of designing the optimal self-assembly conﬁguration of PAs in
pH ranges which reﬂect biological systems [76,77].
3.2. Nerve regeneration
The nanoﬁber self-assembly framework of PAs promotes the mi-
gration and proliferation of neural cells [78]. Experimental data sug-
gests that the bioactive epitope region of PAs promotes neural cell
proliferation [79–81]. The bioactive epitopes of PAs are customizable
to suit different purposes [82,83]. For instance, integrins would pro-
mote adherence of neural cells [84], while RGD motifs and IKVAV se-
quences facilitate neural cell growth and proliferation [85].Fig. 3. Nerve conduit to support nerve regeneration. An artiﬁcial nerve conduit should functi
regeneration. Copyright © 2006 Elsevier B.V. Reproduced with permission from [35].IKVAV is a pentapeptide, made up of a sequence of amino acids
Ile-Lys-Val-Ala-Val, ﬁrst identiﬁed in the A chain of laminin [86].
IKVAV is a neurite-promoting laminin epitope [87], and has been
demonstrated to upregulate the proliferation of neural cells [88]
(Fig. 6). In addition, the presence of IKVAV reduces astrocyte forma-
tion and hence minimizing the risk of glial scars [89]. Furthermore,
it also inhibits apoptosis and mitigates astrogliosis [90] (Fig. 7). In
terms of incorporation of a bioactive epitope on PAs, IKVAV and
RGD appear to be the two most widely studied molecules for the ap-
plication of developing nerve conduits.
Sonic hedgehog homolog (SHH) is a protein that is part of the
hedgehog signaling pathway, and is thought to play a vital function
in nerve regeneration during injury. Experimental data suggestson as a protective sheath, with the ability to deliver small molecules favorable for nerve
Table 2
Nerve conduits used in humans. Keys: ePTFE, expanded polytetraﬂuoroethylene; Pat, patients; PGA, polyglycolic acid; PLCL, polylactide-caprolactone; NDL, nerve defect length.
Material NDL (mm) No. of pat Outcome Ref.
Silicone
3 3 • Highlights potential difﬁculties in using silicone as a sheath
• Deterioration in nerve function required removal of silicone conduits.
[57]
3 1 Recovery of motor and sensory functions in ulnar nerve in wrist [58]
3–5 2 Recovery of motor and sensory functions in median nerve in forearm [59]
3–5 11 Recovery of motor and sensory functions in median and ulnar nerves in forearm, using silicone as a sheath [60]
30–50 11 Motor and sensory recovery observed in median nerve, ulnar and radial nerve [61]
20–50 26 Recovery of motor and sensory function of median and ulnar nerve, with nerve injury gaps b3 mm. [62]
3–5 7 Recovery of motor and sensory functions in median and ulnar nerves in forearm [63]
3–5 17 5-year follow up of tubular repair of median and ulnar nerve in forearm indicates favorable results with
little or no side effects.
[64]
ePTFE
29 1 Recovery of motor and sensory functions of a 2.9 cm ulnar nerve gap in wrist [42]
15–60 43 Recovery of motor and sensory functions of median and ulnar nerves, with gaps b40 mm [43]
2–15 7 Recovery of sensory function in 2 pats. Only effective with nerve gaps b3 mm [44]
3 6 • Poor results observed
• ePTFE not recommended as nerve conduit
[45]
PGA
5–30 15 Recovery of sensory function digital nerves, with gap transections of up to 3 cm [48]
25 1 Recovery of motor and sensory function of inferior alveolar nerve [49]
2–12 98 Improved sensory function in digital nerves, with gaps of b4 mm [50]
20 1 Effective in mitigating neuroma pain by facilitating neural regeneration [51]
Not stated 1 Functional recovery of peripheral nerve in hip joint [52]
20–65 2 Attenuation of type II complex regional pain syndrome; motor and sensory recovery observed in digital nerves [53]
25–36 2 Functional recovery by 65 days after surgery in proper digital nerve and superﬁcial peroneal nerve [54]
10–30 7 Motor and sensory recovery in facial nerve, with gap transections of b30 mm [55]
10–40 17 Good clinical results observed in digital nerve lesion [56]
PLCL
5–12 2 Report of a technically successful operation [46]
2–20 17 Recovery of sensory nerve function in peripheral nerve defect of b20 mm [47]
Collagen
2.5–20 96 Improvement in 45% of patients [65]
12.5 14 Functional recovery in 9 patients [66]
18–50 9 Functional recovery in all patients [67]
Not stated 9 Functional recovery in 8 out of 9 patients [68]
2.8–17.3 5 Functional recovery in all patients [69]
347A. Tan et al. / Journal of Controlled Release 163 (2012) 342–352that SHH-incorporated PAs reduce apoptosis and aid nerve regener-
ation in a cavernous nerve injury rodent model [8]. Furthermore,
SHH-incorporated PAs ensure that the bioactive epitope is targeted
locally rather than systemically, as activation of the SHH is linked
to the progression of cancer.
RGD (Arg-Gly-Asp) is a tripeptide which features prominently in
integrins, and is known to mediate peripheral neuron regeneration
[91]. Integration of RGD into PAs demonstrated that these bioactive
PAs promoted cell proliferation and differentiation. A plethora of pep-
tide sequences can also be incorporated into PAs, making these
nanoﬁbers extremely versatile and customizable.
Unlike conventional materials used in nerve tissue engineering, PAs
can be directly injected in vivo into models and spontaneously self-
assemble into nanoﬁbers in aqueous solutions. Furthermore, PAs can
function as biomimetic materials exempliﬁed by collagen-mimetic
PAs [92]. Conventional materials often rely on electrospinning as a
manufacturing method to achieve ﬁber-like structures suitable for use
in nerve regeneration. The self-assembly nature of PAs allows them to
circumvent costly manufacturing methods. However, in contrast to
conventional manufacturing methods like electrospinning where qual-
ity and batch-to-batch variability can be tightly controlled, merely rely-
ing on self-assembly as a method of large-scale commercial production
is still an experimental concept. Perhaps the next stepwould be to care-
fully compare and contrast the robustness of self-assemled PAs to
electrospun nanoﬁbers. Given that the constituent elements in PAs
and external factors like pH can affect its structural assembly,parameters must be ﬁnely tuned and optimized in order for PA
nanoﬁbers to be used as a full-ﬂedged commercialized medical product
[93].
3.3. Controlled drug release & delivery
Apart from being purely constructs for nerve regeneration, PAs can
also function as efﬁcient drug and gene delivery platforms. Various
therapeutic agents can be incorporated into PAs to augment the recov-
ery process and minimize immune response. It has been shown that
controlled release of the anti-inﬂammatory drug dexamethasone can
be achieved when incorporated into PAs [94]. The sustained and con-
trolled release of dexamethasone reduced the occurrence of inﬂam-
mation, thereby speeding up recovery time, which is crucial in
regenerative medicine. The application of PAs as gene delivery plat-
forms has also been explored, using antisense oligonucleotide as a
payload [95].
PAs can also function as biomimetic materials, as seen in a study
where vascular endothelial growth factor (VEGF)-PAs and basic ﬁbro-
blast growth factor (bFGF)-PAs were able to enhance bioactivity via
direct cell signaling to promote angiogenesis [96,97], and was moni-
tored over a month in a sustained release fashion. Along the same
lines, heparin (which is prone to enzymatic degradation) was incor-
porated into PAs to promote angiogenesis and extend its period of
bioactivity [98]. As heparin is derived from animals (which harbors
a risk of immunogenicity), heparin-mimetic PAs were also developed
Table 3
FDA-approved nerve conduits, with date of approval. Keys: PGA, polyglycolic acid; PVA, polyvinyl alcohol.
Product Name Date Price Material Degradation time (months) Company
Neurotube® 22 Mar 1999 €340 PGA 3 Synovis
NeuraGen® 22 Jun 2001 €1200 Type-I collagen 48 Integra NeuroSciences
NeuroMatrix NeuroFlex® 21 Sept 2001 €600 Type-I collagen 7 Collagen Matrix Inc.
AxoGuard™ Nerve Connector 15 May 2003 Not stated Porcine small intestine mucosa 3 Cook Biotech Products
Neurolac® 10 Oct 2003 €700–€1800 Poly-DL-lactide-caprolactone 16 Polyganics BV
SaluBridge® 24 Nov 2003 Not stated PVA hydrogel Non-degradable Salumedica LCC
SaluTunnel™ Nerve Protector™ 5 Aug 2010 Not stated PVA Non-degradable Salumedica LCC
348 A. Tan et al. / Journal of Controlled Release 163 (2012) 342–352to circumvent this [99]. This study highlights the potential of delivering
molecules with a short half-life or inadequate retention in a sustained
and controlled manner using PAs as biomimetic supramolecular struc-
tures, which preclude the need of repeated administration or injection.Fig. 4. FDA-approved nerve conduits. Scanning electron microscopy of A NeuraGen®
(made from collagen), B Neurolac® (made from poly-DL-lactide-caprolactone), C
Neurotube® (made from polyglycolic acid). Scale bar=4 mm. Copyright © 2006 Con-
gress of Neurological Surgeons. Reproduced with permission from [1].Interestingly enough, PAs can also be incorporated into liposomes
and would function as bioactive ligands for targeted drug delivery
[100] (Fig. 8). This would open up the possibility of PAs having dual
functionality of being used as nerve conduits and also drug delivery
platforms to treat neoplastic neuromas. Conversely, it has been
reported that inclusion of phospholipids into PAs can increase acces-
sibility of the bioactive epitopes, enhancing its drug-releasing or
cell-regenerative capacity [101].
4. Conclusion and perspectives
The ﬁeld of bioengineering nerve conduits for regenerative medi-
cine is advancing rapidly [102,103]. Despite the tremendous amount
of research conducted in the search for appropriate materials for
nerve conduits, the FDA currently approves only a few materials for
that purpose, namely PGA, Type-I collagen, PLCL, and PVA. Further-
more, current materials used in FDA-approved nerve conduits suffer
from various limitations. For example, PGA suffers from a high rate
of degradation, which would compromise on mechanical properties.
Collagen is a natural material, which still poses a risk of immunogenic
response, and batch-to-batch variability in terms of the manufactur-
ing process is still a teething problem. The relative rigidity and inﬂex-
ibility of PLCL necessitate the use of a larger needle during suturing.
Lumen blockage and incomplete degradation leading to neuroma for-
mation are also limiting factors for PLCL. PVA is non-biodegradable
which harbors a risk of nerve compression, which might have a detri-
mental effect on the recovery process.
Mounting evidence suggests that PAs can indeed function as via-
ble materials for nerve conduits. The dynamic versatility of PAs
being able to harbor bioactive molecules to sustain the growth and
development of neurons is a fascinating insight to the realm of regen-
erative medicine. Indeed, much research has been conducted into elu-
cidating the atomistic molecular dynamics and tunability of PAs and
their ability to self-assemble into nano-structures [104–106]. At pres-
ent, there are no in vivo studies comparing the use of FDA-approved
nerve conduits with PAs. This would undoubtedly be a pertinent
starting point to assess the comparative clinical potential for PAs to
be used as nerve conduits.
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